Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients

Creative Commons License

Tecen-Yucel K., Bayraktar-Ekincioglu A., YILDIRIM T., YILMAZ Ş. R., Demirkan K., ERDEM Y.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, cilt.26, sa.10, ss.1291-1296, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 10
  • Basım Tarihi: 2020
  • Doi Numarası: 10.18553/jmcp.2020.26.10.1291
  • Dergi Adı: JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1291-1296
  • Hacettepe Üniversitesi Adresli: Evet

Özet

BACKGROUND: Potential drug-drug interactions (pDDIs) with immunosuppressive drugs are frequently observed in renal transplant recipients. Drug interaction programs are acknowledged as a fundamental tool to alert physicians to pDDIs, but there is a high concern about variation among different programs in terms of quality and reliability of information.